Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Facciabene

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Oncoimmunology|December 7, 2017
Trial watch: DNA-based vaccines for oncological indicationsStefano Pierini, Renzo Perales-Linares, Mireia Uribe-Herranz, et al.
JCI Insight|August 21, 2020
Ovarian granulosa cell tumor characterization identifies FOXL2 as an immunotherapeutic targetStefano Pierini, Janos L Tanyi, Fiona Simpkins, et al.
Journal of Translational Medicine|May 26, 2011
Time-dependent cytotoxic drugs selectively cooperate with IL-18 for cancer chemo-immunotherapyIoannis Alagkiozidis, Andrea Facciabene, Marinos Tsiatas, et al.
Nature Medicine|December 25, 2007
Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapyRonald J Buckanovich, Andrea Facciabene, Sarah Kim, et al.
The Journal of Clinical Investigation|March 20, 2014
Tumor endothelial marker 1-specific DNA vaccination targets tumor vasculatureJohn G Facciponte, Stefano Ugel, Francesco De Sanctis, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
"Tumor-to-endothelium mitochondrial transfer licenses endothelial cells for CD8 <sup>+</sup> T cell recognition via mitochondrial neoantigen presentation"Francesca Costabile, Pierini Stefano, Renzo Perales-Linares, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 18, 2015
A Tumor Mitochondria Vaccine Protects against Experimental Renal Cell CarcinomaStefano Pierini, Chongyun Fang, Stavros Rafail, et al.
Cancer|May 28, 2009
Intraepithelial T cells and tumor proliferation: impact on the benefit from surgical cytoreduction in advanced serous ovarian cancerSarah F Adams, Douglas A Levine, Mark G Cadungog, et al.
Nature|July 15, 2011
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cellsAndrea Facciabene, Xiaohui Peng, Ian S Hagemann, et al.
Journal for Immunotherapy of Cancer|February 10, 2021
Combination of vasculature targeting, hypofractionated radiotherapy, and immune checkpoint inhibitor elicits potent antitumor immune response and blocks tumor progressionStefano Pierini, Abhishek Mishra, Renzo Perales-Linares, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Oncoimmunology|December 7, 2017
Trial watch: DNA-based vaccines for oncological indicationsStefano Pierini, Renzo Perales-Linares, Mireia Uribe-Herranz, et al.
JCI Insight|August 21, 2020
Ovarian granulosa cell tumor characterization identifies FOXL2 as an immunotherapeutic targetStefano Pierini, Janos L Tanyi, Fiona Simpkins, et al.
Journal of Translational Medicine|May 26, 2011
Time-dependent cytotoxic drugs selectively cooperate with IL-18 for cancer chemo-immunotherapyIoannis Alagkiozidis, Andrea Facciabene, Marinos Tsiatas, et al.
Nature Medicine|December 25, 2007
Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapyRonald J Buckanovich, Andrea Facciabene, Sarah Kim, et al.
The Journal of Clinical Investigation|March 20, 2014
Tumor endothelial marker 1-specific DNA vaccination targets tumor vasculatureJohn G Facciponte, Stefano Ugel, Francesco De Sanctis, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
"Tumor-to-endothelium mitochondrial transfer licenses endothelial cells for CD8 <sup>+</sup> T cell recognition via mitochondrial neoantigen presentation"Francesca Costabile, Pierini Stefano, Renzo Perales-Linares, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 18, 2015
A Tumor Mitochondria Vaccine Protects against Experimental Renal Cell CarcinomaStefano Pierini, Chongyun Fang, Stavros Rafail, et al.
Cancer|May 28, 2009
Intraepithelial T cells and tumor proliferation: impact on the benefit from surgical cytoreduction in advanced serous ovarian cancerSarah F Adams, Douglas A Levine, Mark G Cadungog, et al.
Nature|July 15, 2011
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cellsAndrea Facciabene, Xiaohui Peng, Ian S Hagemann, et al.
Journal for Immunotherapy of Cancer|February 10, 2021
Combination of vasculature targeting, hypofractionated radiotherapy, and immune checkpoint inhibitor elicits potent antitumor immune response and blocks tumor progressionStefano Pierini, Abhishek Mishra, Renzo Perales-Linares, et al.
Pageof 5